These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27286845)

  • 1. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
    Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
    J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
    Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
    Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary neurolymphomatosis of spinal nerve roots detected by ¹⁸F-FDG PET/CT: a case report and differential diagnosis of the case.
    Wang Y; Wang J; Jiang C; Peng Q; Wu M; Ma X
    Hell J Nucl Med; 2015; 18(3):261-3. PubMed ID: 26574697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
    Jeong J; Kim SW; Sung DH
    J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 18F-FDG PET/CT in Neurolymphomatosis: A Comprehensive Imaging Approach.
    Usmani S; Jain A; Riyami KA; Ahmed N; Al-Sukaiti R; Shamim MS
    J Pak Med Assoc; 2024 Apr; 74(4):822-824. PubMed ID: 38751291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary lymphoma involving cranial nerves and cauda equina detected by (18)F-FDG PET/CT and MRI.
    Wang G; Liu Y; He F
    Nuklearmedizin; 2016 Sep; 55(5):N46-8. PubMed ID: 27668300
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurolymphomatosis: MRI and (18) FDG-PET features.
    Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tan X; Sun X; Yuan H; He L; Ding C; Jiang L
    Hell J Nucl Med; 2022; 25(3):285-296. PubMed ID: 36507885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell peripheral neurolymphomatosis: MRI and
    DeVries AH; Howe BM; Spinner RJ; Broski SM
    Skeletal Radiol; 2019 Jul; 48(7):1043-1050. PubMed ID: 30666391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis.
    Salm LP; Van der Hiel B; Stokkel MP
    Nucl Med Commun; 2012 Sep; 33(9):907-16. PubMed ID: 22714006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT/MRI Fusion Images Showing Cranial and Peripheral Nerve Involvement in Neurolymphomatosis.
    Trevisan AC; Ribeiro FB; Itikawa EN; Alexandre LS; Pitella FA; Santos AC; Simões BP; Wichert-Ana L
    Indian J Nucl Med; 2017; 32(1):77-78. PubMed ID: 28242998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
    Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
    Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases.
    Canh NX; Tan NV; Tung TT; Son NT; Maurea S
    Asia Ocean J Nucl Med Biol; 2014; 2(1):57-64. PubMed ID: 27408859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
    Liu Y
    Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurolymphomatosis as a late relapse of non-Hodgkin's lymphoma detected by 18F-FDG PET/CT: a case report.
    Kajáry K; Molnár Z; Mikó I; Barsi P; Lengyel Z; Szakáll S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):39-42. PubMed ID: 23683830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary peripheral neurolymphomatosis mimicking synovial sarcoma: FDG PETCT to the rescue.
    Padma S; Sundaram PS; Praveen Kumar SL
    J Cancer Res Ther; 2014; 10(3):726-9. PubMed ID: 25313768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma.
    Matsue K; Hayama BY; Iwama K; Koyama T; Fujiwara H; Yamakura M; Takeuchi M; O'uchi T
    Cancer; 2011 Oct; 117(19):4512-21. PubMed ID: 21448935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
    Lin M; Kilanowska J; Taper J; Chu J
    Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy.
    Suga K; Yasuhiko K; Matsunaga N; Yujiri T; Nakazora T; Ariyoshi K
    Clin Nucl Med; 2011 Jan; 36(1):73-6. PubMed ID: 21157220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.